Assessment of 111In-Ibritumomab pretreatment imaging in 90Y-Ibritumomab radioimmunotherapy for relapsed or refractory low-grade B cell lymphoma.

被引：0
|
作者：
Kaneko, K. [1 ]
Uike, N. [1 ]
Shinozaki, K. [1 ]
Choi, I. [1 ]
机构：
[1] Kyushu Natl Canc Ctr, Fukuoka, Japan
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2013年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S372 / S372
页数：1
相关论文
共 50 条
  • [1] Does tumoral 111In-ibritumomab accumulation correlate with therapeutic effect and outcome in relapsed or refractory low-grade B-cell lymphoma patients undergoing 90Y-ibritumomab radioimmunotherapy?
    Kaneko, Koichiro
    Choi, Ilseung
    Nakagawa, Makoto
    Shinozaki, Kenji
    Uike, Naokuni
    EUROPEAN RADIOLOGY, 2014, 24 (12) : 3191 - 3198
  • [2] Does tumoral 111In-ibritumomab accumulation correlate with therapeutic effect and outcome in relapsed or refractory low-grade B-cell lymphoma patients undergoing 90Y-ibritumomab radioimmunotherapy?
    Koichiro Kaneko
    Ilseung Choi
    Makoto Nakagawa
    Kenji Shinozaki
    Naokuni Uike
    European Radiology, 2014, 24 : 3191 - 3198
  • [3] 90Y-Ibritumomab Therapy in Refractory Non-Hodgkin's Lymphoma: Observations from 111In-Ibritumomab Pretreatment Imaging
    Iagaru, Andrei
    Gambhir, Sanjiv Sam
    Goris, Michael L.
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (11) : 1809 - 1812
  • [4] Efficacy of 90Y-ibritumomab tiuxetan treatment for relapsed and refractory low-grade B-cell and mantle cell lymphoma
    Motomura, Sayuri
    Suda, Atsuhiro
    Inoue, Misato
    Takashi, Yoshikawa
    Atsushi, Yamamoto
    Hiroko, Hidai
    Hisashi, Tsutsumi
    Junichi, Nagashima
    ANNALS OF ONCOLOGY, 2015, 26 : 109 - 109
  • [5] Imaging with 111In-Ibritumomab and 18F-FDG PET/CT in 90Y-Ibritumomab radioimmunotherapy of non-Hodgkin's lymphoma
    Banzo, I.
    Martinez-Rodriguez, I.
    Quirce, R.
    Jimenez-Bonilla, J.
    Sainz-Esteban, A.
    Barragan, J.
    Portilla-Quattrociocchi, H.
    Medina-Quiroz, P.
    Carril, J.
    Marques Valdecilla, H. U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S419 - S419
  • [6] Radioimmunotherapy with 90Y-ibritumomab tiuxetan for a hemodialysis patient with relapsed follicular lymphoma
    Fukuno, Kenji
    Tsurumi, Hisashi
    Yamada, Toshiki
    Iida, Takayoshi
    Takahashi, Takeshi
    Moriwaki, Hisataka
    LEUKEMIA & LYMPHOMA, 2013, 54 (12) : 2731 - 2733
  • [7] Assessment of Metabolic Response to Radioimmunotherapy with 90Y-Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
    Storto, Giovanni
    De Renzo, Amalia
    Pellegrino, Teresa
    Perna, Fabiana
    De Falco, Teresa
    Erra, Paola
    Nardelli, Anna
    Speranza, Antonio
    Klain, Michele
    Rotoli, Bruno
    Pace, Leonardo
    RADIOLOGY, 2010, 254 (01) : 245 - 252
  • [8] Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma
    Gordon, LI
    Witzig, TE
    Wiseman, GA
    Flinn, IW
    Spies, SS
    Silverman, DH
    Emmanuolides, C
    Cripe, L
    Saleh, M
    Czuczman, MS
    Olejnik, T
    White, CA
    Grillo-López, AJ
    SEMINARS IN ONCOLOGY, 2002, 29 (01) : 87 - 92
  • [9] Radioimmunotherapy with 90Y Ibritumomab Tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
    Palumbo, B.
    Sabalich, I.
    Falcinelli, F.
    Capponi, M.
    Martelli, M.
    Palumbo, R.
    Sinzinger, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S419 - S419
  • [10] RADIOIMMUNOTHERAPY OF (90Y)-IBRITUMOMAB TIUXETAN FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA AND FOLLICULAR LYMPHOMA
    Yoshida, Isao
    Kogure, Yuuki
    Kajihara, Makoto
    ANNALS OF ONCOLOGY, 2014, 25
12345